- Home
- PROF vs XCBE Comparison
PROF vs XCBE Comparison
Compare PROF & XCBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PROF | XCBE |
|---|---|---|
| Founded | N/A | 2025 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.6M | 279.3M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | PROF | XCBE |
|---|---|---|
| Price | $6.80 | $9.93 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 59.2K | 31.3K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.89 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $16,098,000.00 | N/A |
| Revenue This Year | $92.40 | N/A |
| Revenue Next Year | $64.10 | N/A |
| P/E Ratio | $34.32 | ★ N/A |
| Revenue Growth | ★ 50.73 | N/A |
| 52 Week Low | $3.92 | $9.75 |
| 52 Week High | $8.95 | $9.95 |
Technical Indicators
Market Signals| Indicator | PROF | XCBE |
|---|---|---|
| Relative Strength Index (RSI) | 45.71 | 62.10 |
| Support Level | $6.47 | $9.88 |
| Resistance Level | $7.06 | $9.95 |
| Average True Range (ATR) | 0.33 | 0.01 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 29.69 | 71.43 |
Price Performance
Historical ComparisonAbout PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
About XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares
X3 Acquisition Corp Ltd is a blank check company.